Search research articles
Contact Us
Filters
Showing results (101-110 of 333) with videos related to
Page
of 34
Sort By:
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
Christian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Oncotarget
|
September 17, 2017
Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
Nadine Gehrke, Marcus A Wörns, Amrit Mann, et al.
Scientific Reports
|
June 6, 2023
Metabolic dysfunction-associated fatty liver disease in people living with HIV
Maurice Michel, Christian Labenz, Angelo Armandi, et al.
Journal of Lipid Research
|
November 13, 2016
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study
Marcin Krawczyk, Monika Rau, Jörn M Schattenberg, et al.
Hepatology Communications
|
December 2, 2024
Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice
Nadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
Plos One
|
June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry
Monika Rau, Peter Buggisch, Stefan Mauss, et al.
Journal of Hepatology
|
January 26, 2018
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation
Nadine Gehrke, Nadine Hövelmeyer, Ari Waisman, et al.
JHEP Reports : Innovation in Hepatology
|
September 22, 2025
Proteomic signatures reflect effects of semaglutide treatment for MASH
Jörn M Schattenberg, Henning Grønbæk, Iris Kliers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 3, 2023
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients
Martin Franck, Katharina John, Sherin Al Aoua, et al.
Digestive Diseases (Basel, Switzerland)
|
July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
Christian Labenz, Vera Prenosil, Sandra Koch, et al.
Page
of 34
Search research articles
Search
Showing results (101-110 of 333) with videos related to
Sort By:
Page
of 34
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
Christian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Oncotarget
|
September 17, 2017
Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation
Nadine Gehrke, Marcus A Wörns, Amrit Mann, et al.
Scientific Reports
|
June 6, 2023
Metabolic dysfunction-associated fatty liver disease in people living with HIV
Maurice Michel, Christian Labenz, Angelo Armandi, et al.
Journal of Lipid Research
|
November 13, 2016
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study
Marcin Krawczyk, Monika Rau, Jörn M Schattenberg, et al.
Hepatology Communications
|
December 2, 2024
Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice
Nadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
Plos One
|
June 16, 2022
Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry
Monika Rau, Peter Buggisch, Stefan Mauss, et al.
Journal of Hepatology
|
January 26, 2018
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation
Nadine Gehrke, Nadine Hövelmeyer, Ari Waisman, et al.
JHEP Reports : Innovation in Hepatology
|
September 22, 2025
Proteomic signatures reflect effects of semaglutide treatment for MASH
Jörn M Schattenberg, Henning Grønbæk, Iris Kliers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 3, 2023
Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients
Martin Franck, Katharina John, Sherin Al Aoua, et al.
Digestive Diseases (Basel, Switzerland)
|
July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
Christian Labenz, Vera Prenosil, Sandra Koch, et al.
Page
of 34